The project seeks to draw on the magnetic properties of new nanoparticles to develop innovative approaches to diagnosing colon cancer.
Along with 14 other international institutions, our nanotechnology center has received funding from the European Community to participate in a project aimed at promoting exchange and collaboration among researchers, creating networks and training human capital. The MagnaMed Project, which is led by the Basque Country University, with the participation of the Universidad Complutense of Madrid,
University of California San Diego, the University of Texas in San Antonio and CEDENNA, among others, aims to design, fabricate, analyze and evaluate magnetic nanostructures with unique spin configurations for the development of innovative diagnostic and therapeutic tools against colorectal cancer. Cancer is the second most important cause of death in Europe and its effective early treatment is key to reducing mortality rates.